Clinical Trial Update: Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

View source ↗

Summary

Real-world observational study PROSPER evaluating mogamulizumab (Poteligeo) in adults with mycosis fungoides and Sézary syndrome; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Poteligeo (mogamulizumab)

Snippet

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: Mycosis Fungoides and Sézary Syndrome | Status: ACTIVE_NOT_RECRUITING